SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950135-99-001750
Filing Date
1999-03-31
Accepted
1999-03-31 00:00:00
Documents
16
Period of Report
1998-12-31

Document Format Files

Seq Description Document Type Size
1 GENZYME CORPORATION 10-K405 162622
2 LEASE, DATED NOVEMBER 12, 1998 EX-10.11 153577
3 1998 DIRECTORS STOCK OPTION PLAN EX-10.22 12806
4 CURRENT SCHEDULE TO THE SEVERANCE AGREEMENT EX-10.27 2086
5 CURRENT SCHEDULE TO INDEMNIFICATION AGREEMENT EX-10.28 994
6 CONSULTING AGREEMENT, DATED 12/14/98 EX-10.30 21236
7 CONSULTING AGREEMENT, DATED 12/31/98 EX-10.31 12924
8 CONSULTING AGREEMENT, DATED 7/1/98 EX-10.32 13199
9 2ND AMEND.AND RESTATED CONVERTIBLE DEBT.AGREEMENT EX-10.37 66672
10 PORTIONS OF 1998 GENZYME GENERAL ANNUAL REPORT EX-13.1 428020
11 PORTIONS OF 1998 GENZYME TISSUE REPAIR ANNUAL EX-13.2 99997
12 PORTION OF 1998 GENZYME MOLECULAR ONCOLOGY ANNUAL EX-13.3 93835
13 SUBSIDIARIES OF THE REGISTRANT EX-21 1760
14 CONSENT OF PRICEWATERHOUSECOOPERS LLP EX-23.1 1535
15 FINANCIAL DATA SCHEDULE EX-27 3407
16 MANAGEMENT AND ACCOUNTING POLICIES EX-99.1 19728
  Complete submission text file 0000950135-99-001750.txt   1097565
Mailing Address ONE KENDALL SQUARE CAMBRIDGE MA 02139
Business Address ONE KENDALL SQ CAMBRIDGE MA 02139 6172527500
GENZYME CORP (Filer) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-14680 | Film No.: 99582093
SIC: 2836 Biological Products, (No Diagnostic Substances)